[A study of pupil dilation using the Mydriasert ophthalmic insert]

Area of Science:

• Ophthalmology
• Pharmacology
• Drug Delivery Systems

Background:

• Pupil dilation is crucial for various ophthalmic examinations and procedures.
• Traditional methods using eye drops for mydriasis can vary in efficacy and patient tolerance.

Purpose of the Study:

• To assess the tolerance and effectiveness of the Mydriasert ophthalmic insert for inducing pupil dilation.
• To compare the Mydriasert insert with conventional tropicamide and phenylephrine eye drops.

Main Methods:

• A comparative study involving 80 patients, with the Mydriasert insert used in one eye and eye drops in the other.
• Two pharmaceutical forms of tropicamide and phenylephrine combination were tested.
• Pupil diameter was measured regularly to determine maximal mydriasis after insert placement or eye drop instillation at different frequencies.

Main Results:

• The Mydriasert insert demonstrated excellent subjective and objective tolerance.
• Maximal mydriasis was significantly greater with the insert compared to eye drops (p < 0.04).
• Mydriasis onset was slower with the insert, requiring approximately 47.3 minutes to reach maximum dilation versus 31.4-38.5 minutes for eye drops (p < 0.001).

Conclusions:

• Mydriasert facilitates significantly greater mydriasis than standard eye drops, despite a lower drug quantity.
• The ophthalmic insert offers a viable alternative for achieving pronounced pupil dilation, albeit with a delayed onset of maximal effect.